UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
|
Genesis
Biopharma, Inc.
|
|
(Name
of Issuer)
|
|
Common
Stock
|
|
(Title
of Class of Securities)
|
|
37182R102
|
|
(CUSIP
Number)
|
|
March
15, 2010
|
|
(Date
of Event Which Requires Filing of this
Statement)
|
Check the
appropriate box to designate the rule pursuant to which this Schedule is
filed:
¨ Rule
13d-1(b)
ý Rule
13d-1(c)
¨ Rule
13d-1(d)
*The
remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall not be subject to all other provisions of the Act (however, see the
Notes).
|
CUSIP
No.
|
37182R102
|
|||||||
| 1 |
NAMES OF REPORTING PERSONS:
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES
ONLY):
|
||||
|
|
|||||
|
Batavia
Holdings Limited
|
|||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS): |
||||
|
(a) o
|
|||||
|
(b) o
|
|||||
| 3 | SEC USE ONLY: | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
|
Hong
Kong
|
|||||
| 5 | SOLE VOTING POWER: | ||||
|
NUMBER
OF
|
0
|
||||
|
|
|||||
|
SHARES
|
6 | SHARED VOTING POWER: | |||
|
BENEFICIALLY
|
|||||
|
OWNED
BY
|
5,854,753
|
||||
|
|
|||||
|
EACH
|
7 | SOLE DISPOSITIVE POWER: | |||
|
REPORTING
|
|||||
|
PERSON
|
0
|
||||
|
|
|||||
|
WITH:
|
8 | SHARED DISPOSITIVE POWER: | |||
|
5,854,753
|
|||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
|
5,854,753
|
|||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
|
o
|
|||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
|
8.0%
|
|||||
| 12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
|
CO
|
|||||
2
|
CUSIP
No.
|
37182R102
|
|||||||
| 1 |
NAMES OF REPORTING PERSONS:
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES
ONLY):
|
||||
|
|
|||||
|
Janny
Onggara
|
|||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS): |
||||
|
(a) o
|
|||||
|
(b) o
|
|||||
| 3 | SEC USE ONLY: | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
|
Indonesia
|
|||||
| 5 | SOLE VOTING POWER: | ||||
|
NUMBER
OF
|
0
|
||||
|
|
|||||
|
SHARES
|
6 | SHARED VOTING POWER: | |||
|
BENEFICIALLY
|
|||||
|
OWNED
BY
|
5,854,753
|
||||
|
|
|||||
|
EACH
|
7 | SOLE DISPOSITIVE POWER: | |||
|
REPORTING
|
|||||
|
PERSON
|
0
|
||||
|
|
|||||
|
WITH:
|
8 | SHARED DISPOSITIVE POWER: | |||
|
5,854,753
|
|||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
|
5,854,753
|
|||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
|
o
|
|||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
|
8.0%
|
|||||
| 12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
|
IN
|
|||||
3
Item
1(a). Name of Issuer.
The name
of the issuer is Genesis Biopharma, Inc. (the “Issuer”).
Item
1(b). Address of Issuer’s Principal Executive Offices.
The
address of the Issuer’s principal executive office is 1601 N. Sepulveda Blvd., #632,
Manhattan Beach, California, 90266.
Item
2(a). Name of Person Filing.
This
Schedule 13G (this “Schedule”) is filed
on behalf of Batavia Holdings Limited, a Hong Kong company (“Batavia”), and Janny
Onggara, an Indonesian citizen.
This
Schedule related to the securities directly owned by Batavia. Ms. Onggara is the
Director and sole shareholder of Batavia and, as a result of her control over
Batavia, Ms. Onggara is deemed to beneficially own the securities of Batavia
under Section 13(d) of the Securities Exchange Act of 1934, as
amended. Batavia and Ms. Onggara are referred to herein as the
“Reporting Persons.”
Item
2(b). Address of Principal Business Office, or, if None,
Residence.
The
business address of each of Batavia and Ms. Onggara is 19/F, Seaview Commercial
Building, 21-24 Connaught Road West, Hong Kong.
Item
2(c). Citizenship.
Batavia
is a Hong Kong company. Ms. Onggara is a citizen of
Indonesia.
Item
2(d). Title of Class of Securities.
The title
of the class of securities to which this statement relates is the common stock
of the Issuer (the
“Common
Stock”).
Item
2(e). CUSIP No.
The CUSIP
number is 37182R102.
|
Item
3.
|
If
This Statement is Filed Pursuant to Rule 13d-1(b) or 13d-2(b), Check
Whether the Person Filing is a:
|
|
(a)
|
o
|
Broker
or dealer registered under Section 15 of the Act
|
|
(b)
|
o
|
Bank
as defined in Section 3(a)(6) of the Act
|
|
(c)
|
o
|
Insurance
Company as defined in Section 3(a)(19) of the Act
|
|
(d)
|
o
|
Investment
Company registered under Section 8 of the Investment Company Act of
1940
|
|
(e)
|
o
|
Investment
Adviser registered under section 203 of the Investment Advisers Act of
1940
|
|
(f)
|
o
|
Employee
Benefit Plan, Pension Fund which is subject to the provisions of the
Employee Retirement Income Security Act of 1974 or Endowment Fund; see
Rule 13d-1(b)(1)(ii)(F)
|
|
(g)
|
o
|
Parent
Holding Company, in accordance with Rule 13d-1(b)(1)(ii)(G) (Note: See
Item 7)
|
|
(h)
|
o
|
Group,
in accordance with Rule
13d-1(b)(1)(ii)(H).
|
4
|
Item
4.
|
Ownership.
|
The
information required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the
cover pages and is incorporated herein by reference.
As of
December 17, 2010, Batavia beneficially owns 5,854,753 shares of the Issuer’s
Common Stock, representing 8.0% of the Issuer’s Common Stock then
outstanding.
Janny
Onggara did not directly own any securities of the Issuer. However,
as Batavia’s Director and sole shareholder, Ms. Onggara has the power to vote,
or to direct the vote, and to dispose of, or to direct the disposition of, the
securities held by Batavia. As a result of her control over Batavia,
Ms. Onggara is deemed to beneficially own the securities held by
Batavia.
|
Item
5.
|
Ownership
of Five Percent or Less of a Class.
|
If this
Schedule is being filed to report the fact that as of the date hereof the
Reporting Person has ceased to be the beneficial owner of more than five percent
of the class of securities, check the following [ ].
|
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another
Person.
|
Not
Applicable.
|
Item
7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding
Company.
|
Not
Applicable.
|
Item
8.
|
Identification
and Classification of Members of the
Group.
|
Not
Applicable.
|
Item
9.
|
Notice
of Dissolution of Group.
|
Not
Applicable.
|
Item
10.
|
Certifications.
|
By
signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
5
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and
correct.
|
Dated: December
17, 2010
BATAVIA
HOLDINGS LIMITED
|
Dated: December
17, 2010
|
||
|
By:
|
/s/
Janny Onggara
|
/s/
Janny Onggara
|
|
|
Janny
Onggara, Director
|
JANNY
ONGGARA
|
||
6
EXHIBIT A
AGREEMENT
OF JOINT FILING
The
undersigned hereby agree that the statement on Schedule 13G filed herewith (and
any amendments thereto), is being filed jointly with the Securities and Exchange
Commission pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of
1934, as amended, on behalf of each such person.
|
Dated: December
17, 2010
BATAVIA
HOLDINGS LIMITED
|
Dated: December
17, 2010
|
||
|
By:
|
/s/
Janny Onggara
|
/s/
Janny Onggara
|
|
|
Janny
Onggara, Director
|
JANNY
ONGGARA
|
||
7